Skip to main content

DAVENPORT & Co LLC

Position in PFE — Pfizer Inc

CIK 887777 RICHMOND, VA

Position in PFE

as of Jun 30, 2026 · filed Jul 13, 2026
Position Value
$10,748,493
-$1,751,403 QoQ
Shares Held
446,366
+0.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#401
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 85% Shared 0% None 15%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Derivatives in PFE

reported options exposure · as of Mar 31, 2026
CallValue
$348,192
CallShares
12,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

DAVENPORT & Co LLC holds $494,810,441 across 13 Drug Manufacturers - General names. PFE ranks #7 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 PFE
Pfizer Inc
This page
446,366 $10,748,493

All Filings in PFE

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,748,493 446,366
2026-03-31 $348,192 12,400
2026-03-31 $12,499,896 445,153
2025-12-31 $10,925,871 438,790
2025-09-30 $10,933,493 429,101
2025-06-30 $9,901,167 408,464
2025-06-30 $336,936 13,900
2025-03-31 $9,595,472 378,669
2024-12-31 $8,653,343 326,172
2024-09-30 $10,436,082 360,611
2024-06-30 $9,961,943 356,038
2024-03-31 $10,558,431 380,484
2023-12-31 $9,936,551 345,139
2023-09-30 $12,927,410 389,732
2023-06-30 $14,540,612 396,418
2023-03-31 $16,026,036 392,795
2022-12-31 $20,172,009 393,677
2022-09-30 $17,026,315 389,084
2022-06-30 $20,378,230 388,675
2022-03-31 $21,581,256 416,868
2021-12-31 $23,355,987 395,529
2021-09-30 $17,912,374 416,470
2021-06-30 $18,051,859 460,977
2021-03-31 $13,728,597 378,929
2020-12-31 $14,391,863 390,977
2020-09-30 $14,070,839 383,402
2020-06-30 $11,821,487 361,513
2020-03-31 $10,812,474 331,265